Författare: Lindstedt Isak, Nilsson Peter M

Titel: ABC om utredning och behandling av primär hypertoni (serie: Medicinens ABC) 2008 nr 30 sid 2107-12

Läs/ladda hem artikeln:
Översikt
Fullständig referenslista
Artikeln i pdf-format
Artikeln i webbversion
Sid 2107
Sid 2108
Sid 2109
Sid 2110
Sid 2111
Sid 2112
Om Läkartidningens fulltext på Internet
Ämnesord:
Högt blodtryck
Blodtryckssänkande medel
Kostnads-nyttoanalys
Evidensbaserad medicin
Hälsokampanjer


















Sök liknande artiklar

Referenser:
1.Freis ED. A history of hypertension treatment. In: Oparil S, Weber MA, editors. Hypertension. Philadelphia: Elsevier-Saunders; 2005. p. 1-6.
2.Beevers G, Lip GYH, O'Brien E. ABC of Hypertension. London: BMJ Books; 2001. p. 17.
3.Lindholm LH, Agenäs I, Carlberg B, Dahlgren H, De Faire U, Hedblad B, et al. Måttligt förhöjt blodtryck. En systematisk litteraturöversikt. Stockholm: Sta¬tens beredning för medicinsk utvärdering 2004 (Uppdaterad 2007). SBU-rapport 170/1-2.
4.Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hyperten¬sion. J Hypertens 2007; 25:1105-1187.
5.Kahan T. Primär kardiovaskulär prevention - hypertoni och vänsterkammarhypertrofi. Bakgrundsdokument - Information från Läkemedelsverket 3:2006.
6.Thulin T. Högt Blodtryck. I: Lindegärde F, Thulin T, Östergren J, Redaktörer. Kärlsjukdomar - lärobok i medicinsk angiologi. Lund: Studentlitteratur; 2005. p. 119-144.
7.Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially mo¬difiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:937-52.
8.Mancia G, Facchetti R, Bombelli M, Friz HP, Grassi G, Giannattasio C, et al. Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension 2005; 45:1072-1077.
9.Kannel WB. Risk stratification in hypertension: new insights from the Framingham study. Am J Hypertens 2001; 13 (Suppl 1):3-10.
10.Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific rele¬vance of usual blood pressure to vascular mortality: a meta-ana¬lysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13.
11.Parati G, Bilo G, Mancia G. Prognostic and diagnostic value of ambulatory blood pressure monitoring. In: Oparil S, Weber MA, editors. Hypertension. Philadelphia: Elsevier-Saunders; 2005. p. 305-317.
12.Fuchs FD, Maestri MK, Bredemeier M, Cardozo SE, Moreira FC, Wainstein MV, et al. Study of the usefulness of optic fundi examination of patients with hypertension in a clinical setting. J Hum Hypertens 1995; 9:547-551.
13.Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiografic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994; 90:1786-93.
14.Whelton SP, Chin A, Xin X, He J. Effects of aerobic exersice on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002; 136: 493-503.
15.Mulrow CD, Chiquette E, Angel L, Cornell J, Summerbell C, Anagnostelis B, et al. Dieting to reduce body weight for controlling hypertension in adults. Cochrane Database Syst Rev 2000; CD000484.
16.Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative research group. N Engl J Med 1997; 336: 1117-24.
17.Chobanian AV, Hill M. National Heart, Lung, and Blood Institute Workshop on sodium and blood pressure: a critical review of current scientific evidence. Hypertension 2000; 35: 858-863.
18.Beilin LJ, Puddey IB, Burke V. Lifestyle and hypertension. Am J Hypertens 1999; 12: 934-945.
19.Staessen JA, Wang JG, Thijs L. Cardiovascular protec¬tion and blood pressure reduction: a meta-analysis. Lancet 2001;358:1305-15.
20.Lindholm LH, Carlberg B, Samuelsson O. Should beta block¬ers remain first choice in the treatment of primary hyperten¬sion? A meta-analysis. Lancet. 2005; 366: 1545-53.
21.Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113: 1213-1225.
22.Hedberg N, Jacob J. En genomgång av de läkemedel som sänker blodtrycket - en sammanfattning. www.lfn.se
23.Krakoff LR. Initial evaluation and follow-up assessment. In: Oparil S, Weber MA, editors. Hypertension. Philadelphia: Elsevier-Saunders; 2005. p. 295-304.
24.Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004; 292: 2350-2356.